Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer.
作者:
主题词
女(雌)性(Female);人类(Humans);乳腺肿瘤(Breast Neoplasms);肿瘤辅助疗法(Neoadjuvant Therapy);受体, 雌激素(Receptors, Estrogen);Ki-67抗原(Ki-67 Antigen);绝经后期(Postmenopause);乳房切除术(Mastectomy)
DOI
10.1245/s10434-022-12972-5
PMID
36653664
发布时间
2023-12-07
- 浏览0

Annals of surgical oncology
2111-2118页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文